Star Source Multi Trade Limited Responds to BSE Regarding Share Price Movement
Star Source Multi Trade Limited, formerly known as Chemo Pharma Laboratories Limited, responded to a clarification request from the Bombay Stock Exchange (BSE) Limited concerning share price movements. The response, dated April 1, 2026, affirms the company's adherence to regulations outlined in the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.The company stated it has consistently provided the BSE with information impacting operations and performance, including price-sensitive data, as mandated by Regulation 30 and other applicable regulations. Star Source Multi Trade Limited attributes the share price movement to market-driven factors.
Ruchit Mehta, Managing Director & Chief Executive Officer, confirmed the company's ongoing commitment to complying with Regulation 30 of the SEBI (LODR) Regulations, 2015, and assured the BSE of continued updates regarding any relevant events.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.